LILRB1 AND LILRB2 BINDING MOLECULES AND USES THEREOF
The present invention provides novel anti-LILR antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions to treat diseases such as cancer, autoimmune diseases, or allergic inflammation. 本发明提供新颖抗LILR抗体、包含此类抗体的药...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BLOCKS RUDIGER DUNKEN GREGORY SCOTT BRAY MARK R MASON JACQUELINE M |
| description | The present invention provides novel anti-LILR antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions to treat diseases such as cancer, autoimmune diseases, or allergic inflammation.
本发明提供新颖抗LILR抗体、包含此类抗体的药物组合物和使用此类抗体和药物组合物来治疗例如癌症、自身免疫性疾病或过敏性炎症的疾病的治疗方法。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN117321083A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN117321083A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN117321083A3</originalsourceid><addsrcrecordid>eNrjZDDx8fQJcjJUcPRzUQAzjRScPP1cPP3cFXz9fVydQ31cg8GSocFARoiHa5CrvxsPA2taYk5xKi-U5mZQdHMNcfbQTS3Ij08tLkhMTs1LLYl39jM0NDc2MjSwMHY0JkYNAIcMJtM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LILRB1 AND LILRB2 BINDING MOLECULES AND USES THEREOF</title><source>esp@cenet</source><creator>BLOCKS RUDIGER ; DUNKEN GREGORY SCOTT ; BRAY MARK R ; MASON JACQUELINE M</creator><creatorcontrib>BLOCKS RUDIGER ; DUNKEN GREGORY SCOTT ; BRAY MARK R ; MASON JACQUELINE M</creatorcontrib><description>The present invention provides novel anti-LILR antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions to treat diseases such as cancer, autoimmune diseases, or allergic inflammation.
本发明提供新颖抗LILR抗体、包含此类抗体的药物组合物和使用此类抗体和药物组合物来治疗例如癌症、自身免疫性疾病或过敏性炎症的疾病的治疗方法。</description><language>chi ; eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231229&DB=EPODOC&CC=CN&NR=117321083A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231229&DB=EPODOC&CC=CN&NR=117321083A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BLOCKS RUDIGER</creatorcontrib><creatorcontrib>DUNKEN GREGORY SCOTT</creatorcontrib><creatorcontrib>BRAY MARK R</creatorcontrib><creatorcontrib>MASON JACQUELINE M</creatorcontrib><title>LILRB1 AND LILRB2 BINDING MOLECULES AND USES THEREOF</title><description>The present invention provides novel anti-LILR antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions to treat diseases such as cancer, autoimmune diseases, or allergic inflammation.
本发明提供新颖抗LILR抗体、包含此类抗体的药物组合物和使用此类抗体和药物组合物来治疗例如癌症、自身免疫性疾病或过敏性炎症的疾病的治疗方法。</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDx8fQJcjJUcPRzUQAzjRScPP1cPP3cFXz9fVydQ31cg8GSocFARoiHa5CrvxsPA2taYk5xKi-U5mZQdHMNcfbQTS3Ij08tLkhMTs1LLYl39jM0NDc2MjSwMHY0JkYNAIcMJtM</recordid><startdate>20231229</startdate><enddate>20231229</enddate><creator>BLOCKS RUDIGER</creator><creator>DUNKEN GREGORY SCOTT</creator><creator>BRAY MARK R</creator><creator>MASON JACQUELINE M</creator><scope>EVB</scope></search><sort><creationdate>20231229</creationdate><title>LILRB1 AND LILRB2 BINDING MOLECULES AND USES THEREOF</title><author>BLOCKS RUDIGER ; DUNKEN GREGORY SCOTT ; BRAY MARK R ; MASON JACQUELINE M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN117321083A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>BLOCKS RUDIGER</creatorcontrib><creatorcontrib>DUNKEN GREGORY SCOTT</creatorcontrib><creatorcontrib>BRAY MARK R</creatorcontrib><creatorcontrib>MASON JACQUELINE M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BLOCKS RUDIGER</au><au>DUNKEN GREGORY SCOTT</au><au>BRAY MARK R</au><au>MASON JACQUELINE M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LILRB1 AND LILRB2 BINDING MOLECULES AND USES THEREOF</title><date>2023-12-29</date><risdate>2023</risdate><abstract>The present invention provides novel anti-LILR antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions to treat diseases such as cancer, autoimmune diseases, or allergic inflammation.
本发明提供新颖抗LILR抗体、包含此类抗体的药物组合物和使用此类抗体和药物组合物来治疗例如癌症、自身免疫性疾病或过敏性炎症的疾病的治疗方法。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN117321083A |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | LILRB1 AND LILRB2 BINDING MOLECULES AND USES THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T06%3A53%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BLOCKS%20RUDIGER&rft.date=2023-12-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN117321083A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |